LHCVX Holdings Information

LHCVX is a mutual fund with a total of 60 individual holdings. The top holdings are Eli Lilly and Company stock at 9.06%, AstraZeneca at 4.82%, Gilead Sciences at 4.33%, Johnson & Johnson at 3.25%, and Nektar Therapeutics at 3.23%.

Total Holdings

Top 10 Percentage

38.34%

Asset Class

Equity

Fund Category

Health

Assets

8.67M

Forward PE Ratio

23.24

Breakdown by Country

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	9.06%	775
2	LON: AZN	AstraZeneca PLC	4.82%	2,029
3	GILD	Gilead Sciences, Inc.	4.33%	2,647
4	JNJ	Johnson & Johnson	3.25%	1,129
5	NKTR	Nektar Therapeutics	3.23%	3,038
6	NTRA	Natera, Inc.	2.97%	1,151
7	TARS	Tarsus Pharmaceuticals, Inc.	2.88%	3,622
8	GH	Guardant Health, Inc.	2.68%	2,459
9	EBR: ARGX	argenx SE	2.61%	266
10	SWX: NOVN	Novartis AG	2.52%	1,356
11	CVS	CVS Health Corporation	2.42%	2,320
12	MDGL	Madrigal Pharmaceuticals, Inc.	2.27%	350
13	ISRG	Intuitive Surgical, Inc.	2.25%	393
14	COGT	Cogent Biosciences, Inc.	2.23%	4,983
15	SWX: GALD	Galderma Group AG	2.14%	818
16	UNH	UnitedHealth Group Incorporated	2.14%	461
17	CELC	Celcuity Inc.	2.05%	1,349
18	BBIO	BridgeBio Pharma, Inc.	2.03%	2,278
19	COR	Cencora, Inc.	2.02%	525
20	ASND	Ascendis Pharma A/S	2.00%	698
21	ABVX	ABIVAX Société Anonyme	1.90%	1,296
22	EW	Edwards Lifesciences Corporation	1.85%	1,775
23	MIRM	Mirum Pharmaceuticals, Inc.	1.79%	1,467
24	EBR: UCB	UCB SA	1.77%	522
25	DNTH	Dianthus Therapeutics, Inc.	1.73%	1,575

Showing 25 of 60 holdings

Subscribe to see the full list

Activate Now

As of Apr 30, 2026